Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Recent patents disclose new therapeutic agents for depression, schizophrenia, etc.

March 16, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

March 16, 2006

B2 induces inclusion formation: efficacy in cellular models of Huntington's and Parkinson's diseases

March 16, 2006

NXY-059 safe and well tolerated in acute intracerebral hemorrhage study

March 16, 2006

Wex halts enrollment in phase IIb/III Tectin study on DMC's recommendation

March 16, 2006

Recent patents report novel agents for pain, migraine, etc.

March 15, 2006

XenoPort initiates phase III for XP-13512 in RLS

March 15, 2006

Long-term treatment benefits of Flurizan

March 15, 2006

BioMS to study MBP-8298 for relapsing-remitting MS

March 15, 2006

Hana completes development of Zensana

March 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...